Brian Michael Bonnell - 07 Mar 2024 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role
Chief Financial Officer
Signature
By: Paula Darbyshire, Attorney-in-fact For: Brian Bonnell
Issuer symbol
ICUI
Transactions as of
07 Mar 2024
Net transactions value
-$1,412,330
Form type
4
Filing time
11 Mar 2024, 16:28:43 UTC
Previous filing
18 May 2023
Next filing
18 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 +2,145 +17% $0.000000 14,560 07 Mar 2024 Direct F1
transaction ICUI Common Stock Tax liability $123,833 -1,175 -8.1% $105.39 13,385 07 Mar 2024 Direct
transaction ICUI Common Stock Options Exercise $0 +12,872 +96% $0.000000 26,257 07 Mar 2024 Direct F2
transaction ICUI Common Stock Tax liability $743,948 -7,059 -27% $105.39 19,198 07 Mar 2024 Direct
transaction ICUI Common Stock Options Exercise $0 +2,210 +12% $0.000000 21,408 08 Mar 2024 Direct F1
transaction ICUI Common Stock Tax liability $126,678 -1,212 -5.7% $104.52 20,196 08 Mar 2024 Direct
transaction ICUI Common Stock Options Exercise $0 +7,289 +36% $0.000000 27,485 08 Mar 2024 Direct F2
transaction ICUI Common Stock Tax liability $417,871 -3,998 -15% $104.52 23,487 08 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 -2,210 -100% $0.000000* 0 08 Mar 2024 Common Stock 2,210 $0.000000 Direct F1, F3, F4, F5
transaction ICUI Common Stock Options Exercise $0 -2,145 -50% $0.000000 2,146 07 Mar 2024 Common Stock 2,145 $0.000000 Direct F1, F3, F4, F5
transaction ICUI Performance Shares Options Exercise $0 -12,872 -100% $0.000000* 0 07 Mar 2024 Common Stock 12,872 $0.000000 Direct F2, F6, F7
transaction ICUI Performance Shares Options Exercise $0 -7,289 -100% $0.000000* 0 08 Mar 2024 Common Stock 7,289 $0.000000 Direct F2, F6, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are Restricted Stock Units.
F2 These Securities are Performance-based Restricted Stock Units (PRSU).
F3 There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F4 One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
F5 These are restricted stock units that fully vest 3 years from the grant date.
F6 There is neither a purchase price nor an exercise price for the PRSUs.
F7 These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.
F8 These PRSUs were granted on March 8, 2021 and had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 110% of the original grant.